Christoph A. J. von Klot

Patterns of Progression After 68Ga-PSMA-Ligand PET/CT-Guided Radiation Therapy for Recurrent Prostate Cancer

Christoph A. J. von Klot, Daniel Walacides, Thorsten Derlin et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 74 citations

Medicine, Nuclear Medicine, Oncology +14

68Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer

Christoph A. J. von Klot, Axel S. Merseburger, Alena Böker et al. · Nuclear Medicine and Molecular Imaging · 2017 · 71 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Neuroendocrine Differentiation and Response to PSMA-Targeted Radioligand Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Study

Thorsten Derlin, Rudolf A. Werner, Marcel Lafos et al. · Journal of Nuclear Medicine · 2020 · 35 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Influence of short‐term dexamethasone on the efficacy of ¹⁷⁷Lu‐PSMA‐617 in patients with metastatic castration‐resistant prostate cancer

Thorsten Derlin, Jan M Sohns, Sebastian Schmuck et al. · The Prostate · 2020 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

Comparison of 68 Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer

Daniel Walacides, A. Meier, Anne Caroline Knöchelmann et al. · Strahlentherapie und Onkologie · 2019 · 23 citations

Medicine, Nuclear Medicine, Radiology +17